|
LACTB2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.766590E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.037200E-03 |
| Normal-vs-Stage2 |
1.920590E-01 |
| Normal-vs-Stage3 |
7.979200E-03 |
| Normal-vs-Stage4 |
1.258360E-03 |
| Stage1-vs-Stage2 |
6.328200E-01 |
| Stage1-vs-Stage3 |
5.565600E-01 |
| Stage1-vs-Stage4 |
4.318400E-02 |
| Stage2-vs-Stage3 |
4.492800E-01 |
| Stage2-vs-Stage4 |
4.297900E-02 |
| Stage3-vs-Stage4 |
1.175600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.98050000000439E-05 |
| Normal-vs-AfricanAmerican |
6.242100E-02 |
| Normal-vs-Asian |
9.810600E-01 |
| Caucasian-vs-AfricanAmerican |
9.206400E-01 |
| Caucasian-vs-Asian |
1.925710E-02 |
| AfricanAmerican-vs-Asian |
1.050220E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.123800E-02 |
| Normal-vs-Female |
6.13689999999778E-05 |
| Male-vs-Female |
1.810450E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.620800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.983270E-03 |
| Normal-vs-Age(61-80Yrs) |
1.097600E-02 |
| Normal-vs-Age(81-100Yrs) |
1.135350E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.616000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.779400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.073000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.998400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.063600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.287600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.813400E-04 |
| Classical-VS-Follicular |
5.372100E-02 |
| Classical-VS-Other |
2.936400E-01 |
| Classical-VS-Normal |
1.589220E-04 |
| Tall-VS-Follicular |
2.42899999999269E-05 |
| Tall-VS-Other |
6.821600E-03 |
| Tall-VS-Normal |
6.5098000001651E-07 |
| Follicular-VS-Other |
7.060800E-01 |
| Follicular-VS-Normal |
3.670400E-01 |
| Other-VS-Normal |
9.052000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.020800E-01 |
| Normal-vs-N1 |
1.280140E-02 |
| N0-vs-N1 |
7.819900E-02 |
|
|
